Citation Tools
PDFReview
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
Other content recommended for you
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association
- Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS
- Optic neuritis with potential for poor outcome
- Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis
- A practical approach to the diagnosis of spinal cord lesions
- Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein
- Neuromyelitis optica spectrum disorder (NMOSD) presenting as acute transverse myelitis with positive aquaporin 4 antibodies
- CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease
- Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease